3:00 PM - 3:45 PM
ROOM TBD
Key Stakeholder Considerations for the Emerging Gene Therapy Market
In this session, we will review the emergence of gene therapies in the pipeline and how these innovations impact the decision of key stakeholders in the healthcare arena. Hear insights from the panel consisting of payers, manufacturers and data analytics experts on what considerations they make in response to managing these therapies, and how our current healthcare system will likely evolve as a result.
Speakers
Leslie Yendro
